An investigation on behalf of investors in Osmotica Pharmaceuticals plc (NASDAQ: OSMT) shares over potential wrongdoing at Osmotica Pharmaceuticals plc was announced.
San Diego, CA -- (SBWIRE) -- 01/28/2020 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Osmotica Pharmaceuticals plc.
Investors who purchased shares of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Osmotica Pharmaceuticals plc (NASDAQ: OSMT officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Bridgewater, NJ based Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, develops, manufactures, and commercializes specialty products that target markets with underserved patient populations. Osmotica Pharmaceuticals plc reported that its annual Total Revenue rose from $245.74 million in 2017 to $263.7 million in 2018 and that its Net Loss increased from $41.14 million in 2017 to $109.39 million in 2018.
On March 27, 2019, after the markets closed, Osmotica Pharmaceuticals plc announced preliminary results for a second Phase 3 clinical trial of arbaclofen extended-release tablets that failed to beat placebo as measured by the Clinical Global Impression of Change.
Those who purchased shares of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.